Modified cold sore virus injected to fight disfiguring skin tumors
NCT ID NCT07102394
Summary
This early-stage study is testing whether a modified virus (IMLYGIC), already approved for some skin cancers, can be safely injected into the numerous, often painful or itchy, skin tumors caused by neurofibromatosis type 1 (NF1). Researchers will inject the virus directly into the tumors of up to 10 adults with NF1 to see if the treatment is feasible and tolerable, and to check for any signs it can shrink the growths.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NF1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.